Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8196
|
pubmed:dateCreated |
1980-12-18
|
pubmed:abstractText |
Brain type creatine kinase-BB (CPK-BB) was measured by radioimmunoassay in the serum of 113 women with breast cancer and 354 female controls. 80% of women with metastatic breast cancer had levels above 3 ng/ml (control range 0.5--3.7 ng/ml); the highest level was 23 ng/ml. 60% of women with local disease but no evidence of distant metastases showed levels above 3 ng/ml, the highest being 9.0 ng/ml. Of women who had presented with stage I, II, or III disease and postoperatively had no evidence of persistent disease 30% had levels above 3 ng/ml. Serial measurements in 31 patients indicated that the serum CPK-BB correlated with clinical response to treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
673-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6106787-Adolescent,
pubmed-meshheading:6106787-Adult,
pubmed-meshheading:6106787-Aged,
pubmed-meshheading:6106787-Breast Neoplasms,
pubmed-meshheading:6106787-Creatine Kinase,
pubmed-meshheading:6106787-Female,
pubmed-meshheading:6106787-Humans,
pubmed-meshheading:6106787-Middle Aged,
pubmed-meshheading:6106787-Neoplasm Metastasis,
pubmed-meshheading:6106787-Radioimmunoassay
|
pubmed:year |
1980
|
pubmed:articleTitle |
Radioimmunoassay of serum creatine kinase-BB as a tumour marker in breast cancer.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|